Tenex Health, Inc.

Tenex Health, Inc. specializes in developing minimally invasive technologies to treat chronic tendon pain, focusing on innovative solutions that enhance patient recovery while reducing the need for traditional surgery. Founded in 2009 in Lake Forest, US, Tenex Health, Inc. is dedicated to providing advanced treatment options for chronic tendon injuries.

The company was acquired by Trice Medical Inc. in April 2021, from Emergent Financial Group, for undisclosed financial terms. The current CEO is Charles Grant. Tenex Health has completed a total of 4 deals, with its most recent funding round being a PIPE amounting to USD 11.

80 mn, which has raised a total of USD 11. 80 mn to date. Tenex Health specializes in minimally invasive technology designed to treat chronic tendon pain. Their core product offering includes a patented procedure that precisely targets and removes damaged tissue in tendons, alleviating pain without traditional surgical interventions.

This technology was developed in collaboration with the MAYO Clinic, highlighting its clinical validity. The primary end users include patients suffering from chronic tendon injuries, particularly in the elbow, while healthcare providers such as orthopedic surgeons and sports medicine professionals administer the treatment. Tenex Health's solutions are marketed primarily in the United States, focusing on urban healthcare facilities and specialized clinics for sports injuries and rehabilitation. Tenex Health generates revenue through direct transactions with healthcare providers who utilize its minimally invasive treatment for chronic tendon pain.

The pricing structure is based on a fee-for-service model, allowing healthcare practitioners to acquire the technology and services directly from Tenex Health, then bill their patients or insurance providers for treatment. This model supports a streamlined service delivery, enhancing the recovery time for patients compared to traditional surgical methods, and positions Tenex Health competitively within the orthopedic market. Following its recent acquisition in April 2021, Tenex Health plans to enhance its product offerings and expand into new markets, particularly targeting therapeutic areas for elbow, hip, knee, ankle, and foot treatments. The funding secured from its PIPE round will be utilized to improve cost efficiencies and develop alternative, minimally invasive treatments.

The company is focused on leveraging its technology to penetrate additional healthcare settings and explore partnerships within urban and suburban healthcare facilities over the next few years.